procainamide has been researched along with Colonic Neoplasms in 1 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
Colonic Neoplasms: Tumors or cancer of the COLON.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Procainamide was not a potent inhibitor of the de novo methyltransferases DNMT3a and DNMT3b2." | 1.33 | Procainamide is a specific inhibitor of DNA methyltransferase 1. ( Lee, BH; Lin, X; Nelson, WG; Yegnasubramanian, S, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, BH | 1 |
| Yegnasubramanian, S | 1 |
| Lin, X | 1 |
| Nelson, WG | 1 |
1 other study available for procainamide and Colonic Neoplasms
| Article | Year |
|---|---|
Procainamide is a specific inhibitor of DNA methyltransferase 1.
Topics: Allosteric Regulation; Binding Sites; Binding, Competitive; Cell Line, Tumor; Chemoprevention; Colon | 2005 |